COG7 Gene Glycosylation Disorder Type 2E Genetic Test
At DNA Labs UAE, we offer the COG7 Gene Glycosylation Disorder Type 2E Genetic Test to diagnose and guide treatment for this rare genetic disorder. This test analyzes the COG7 gene for mutations using next-generation sequencing (NGS) technology.
Test Components and Price
The COG7 Gene Glycosylation Disorder Type 2E Genetic Test is priced at 4400.0 AED. The test can be performed on blood or extracted DNA samples. Alternatively, one drop of blood can be collected on an FTA card.
Report Delivery and Test Method
The test results are typically delivered within 3 to 4 weeks. The NGS technology is used to analyze the COG7 gene for mutations.
Test Type and Referring Doctor
The COG7 Gene Glycosylation Disorder Type 2E Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.
Test Department and Pre Test Information
The test is conducted in the Genetics department. Before undergoing the COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is advised to draw a pedigree chart of family members affected with this disorder.
Test Details and Symptoms
The COG7 gene is responsible for producing a protein involved in the process of glycosylation. Mutations in this gene can result in COG7 Glycosylation Disorder Type 2E, which affects the body’s ability to properly glycosylate proteins and lipids. Symptoms of this disorder include developmental delays, intellectual disability, seizures, and abnormal facial features.
Conclusion
The COG7 Gene Glycosylation Disorder Type 2E Genetic Test offered by DNA Labs UAE is a crucial diagnostic tool for identifying and managing this rare genetic disorder. By analyzing the COG7 gene for mutations, this test can provide valuable insights for treatment and management strategies.
| Test Name | COG7 Gene Glycosylation disorder type 2E Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for COG7 Gene Glycosylation disorder type 2E NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with COG7 Gene Glycosylation disorder type 2E |
| Test Details |
COG7 gene glycosylation disorder type 2E NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze the COG7 gene for mutations. COG7 gene is responsible for producing a protein that is involved in the process of glycosylation, which is the addition of sugar molecules to proteins and lipids. Mutations in this gene can lead to a rare genetic disorder known as COG7 glycosylation disorder type 2E, which affects the body’s ability to properly glycosylate proteins and lipids. This can result in a wide range of symptoms, including developmental delays, intellectual disability, seizures, and abnormal facial features. The NGS genetic test for COG7 gene mutations can help diagnose this disorder and guide treatment and management strategies. |
